SARS-CoV-2 Infection in Patients with a History of VITT.

Schönborn, Linda; Seck, Sabrina E; Thiele, Thomas; Warkentin, Theodore E; Greinacher, Andreas

Schönborn, Linda; Seck, Sabrina E; Thiele, Thomas; Warkentin, Theodore E; Greinacher, Andreas.

Schönborn L; University Medicine Greifswald, Greifswald, Germany.
Seck SE; University Medicine Greifswald, Greifswald, Germany.
Thiele T; University Medicine Greifswald, Greifswald, Germany.
Warkentin TE; McMaster University, Hamilton, ON, Canada.
Greinacher A; University Medicine Greifswald, Greifswald, Germany andreas.greinacher@med.uni-greifswald.de.

N Engl J Med ; 387(1): 88-90, 2022 07 07.

Article in English | MEDLINE | ID: covidwho-1908347

Subject(s)

COVID-19; Purpura, Thrombocytopenic, Idiopathic; SARS-CoV-2; Vaccines; COVID-19/complications; COVID-19 Vaccines/adverse effects; Humans; Purpura, Thrombocytopenic, Idiopathic/chemically induced; Purpura, Thrombocytopenic, Idiopathic/etiology; Vaccination/adverse effects; Vaccines/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Purpura, Thrombocytopenic, Idiopathic / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2206601

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google